Microsatellite instability in in situ and invasive breast cancers

H Iwase MD, T Toyama MD, H Iwata MD, H Yamashita MD, Y Hara MD, Y Omoto MD, T Kato MD PhD, S Kobayashi MD PhD

Production of matrix metalloproteinases and tissue inhibitors of metalloproteinases in human breast carcinomas

H Iwata MD, H Iwase MD, T Toyama MD, Y Hara MD, Y Omoto MD, Y Okada MD PhD, S Kobayashi MD PhD

Estrogen receptors status of patients subjected to mastectomy for breast cancer with a disease-free interval of no less than 8 years

S Basso Ricci MD, V Fossati MD

Tumor associated proteins of human breast

M Manavi MD, A Schneeweiss MD, M Herz PhD, Y Koshelnick PhD, K Czerwenka MD

Stimulation of steroid/retinoid receptors controls the expression of erbb tyrosine kinase receptors in SK-BR-3 breast cancer cells

M Offterdinger MSc, E Dittrich, SM Schneider MSc, C Dittrich MD, H Huber MD, TW Grunt PhD

A nuclear matrix attachment region (MAR)-binding protein as an early marker for breast malignancy

T Kohwi-Shigematsu PhD, S Galande PhD, LA Dickinson PhD

Expression of lambda-catenin in normal breast tissue and breast carcinomas. a comparative study with epithelial cadherin and alpha,beta catenin

R Hashizume, M Ishii, Y Adachi, H Koizumi,T Yamamura, S Yamaguchi

Fatty acid - dependent or independent regulation of BRCA1 in human breast cancer cells?

N Crespin MSc, JC Maurizis PhD, M Ferrara PhD, P Bougnoux MD PhD, P Rio PhD, YJ Bignon MD PhD, D Bernard-Gallon PhD

Allelic imbalance in early onset breast cancer

M Gentile, K Olsen, S Wingren

Detection of DNA ploidy and s phase fraction in fine-needle aspiration biopsies by flow cytometry in breast tumors

S Hara MD, Y Tagawa MD, H Tuji MD, T Oka MD, T Nagayasu MD, H Ayabe MD

Breast skin microcirculation in patients with breast cancer using helium-neon and near infra-red lasers - a new tool

A Seifalian PhD, G Nabbout MD, T Kelleher SRN, S Parbhoo PhD FRCS

Antimalignin antibody (AMAS) elevation detects persistent or recurrent breast cancer

S Bogoch MD PhD, E Bogoch MD

Telomerase activity and telomere length during the progression of human breast cancer

SA Imam PhD, MS Kim BS, L Anker MD, RE Law PhD, CR Taylor MD PhD

Progressive weight gain in women and breast cancer risk: opportunity for breast cancer prevention

NB Kumar PhD, GH Lyman MD MPH, K Allen BS, CE Cox MD, DV Schapira MBChB

Clinical implications of progesterone receptor status and s-phase fraction as prognostic factors in relation to axillary nodal status and tumour size in operable breast cancer

JP Garne

Prognostic significance of erbB2, p53, cl-2, and thymidine phosphorylase expression in breast carcinoma

M Watatani MD, K Nishimura MD, H Inui MD, T Hojo MD, H Yamauchi MD, K Ueda MD, M Yasutomi MD

Correlation between PCNA and first generation markers in breast cancer prognosis

MR Risca MD, I Neagoe, L Lazar MD, E Neagoe MD

Influence of the extraction procedure on PAI-2 and upar assays in breast cancer tissues

C Bouchet, F Spyratos, C Andrieu, S Deytieux, V Becette, J Oglobine

Chemoprevention of mammary carcinoma by targretin(TM) (lgd1069): an RXR selective ligand

ED Bischoff BS, WW Lamph PhD, RA Heyman PhD, MM Gottardis PhD

Chronic active hepatitis and liver cirrhosis in association with combined tamoxifen/tegafur adjuvant therapy

S Maruyama MD, C Hirayama MD, J Abe MD, J Tanaka MD, K Matsui MD

Weight gain associated with tamoxifen: fact or artifact?

NB Kumar PhD, KA Allen BS, A Cantor PhD, C Cox MD, GH Lyman MD MPH, H Greenberg MD, S Shah

Dynamics of DNA flow cytometry (DNA FCM) parameters in patients with locally advanced breast cancer (LABC) treated with neo-adjuvant chemotherapy (preliminary results)

V Bogatyrev MD, M Shomova PhD, V Letyagin MD, I Visotskaya PhD, E Pogodina PhD

Beta-interferon (beta-IFN), retinoids (R) and tamoxifen (TAM) combination in breast cancer: results from biological and clinical studies

F Recchia, G Sica, G Lama, S De Filippis

In vitro potentiation by lonidamine of the sc-rip saporin 6 effect in human primary breast cancer cells

A Gasperi-Campani MD PhD, W Zoli PhD, L Roncuzzi PhD

The role of (99m)tc-sestamibi scintigraphy and tomoscintigraphy for the detection of breast cancer metastases

C Soler MD, N Prevot MD, M Moncet-Soler MD, P Beauchesne MD, F Dubois MD